Clinical Trial Update: Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients [Phase 1]

View source ↗

Summary

This update reports Phase 1 results for multiple rising oral doses of BI 1060469 tested in healthy subjects and patients with mild asthma. The study status indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• BI 1060469

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 1 | Status: COMPLETED